BIO-Europe Spring 2019: Themis Bioscience Harnesses Measles Vector For Immune Modulation

 
• By Mike Ward
  
Video interview
Themis Bioscience CEO Erich Tauber speaks to Scrip
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from R&D

More from Scrip